- New
Breast tissue marker BIOMARC 11G Mammotome 16,5cm Box of 10 sterile markers
Site marker to be implanted in the breast before neoadjuvant therapy in order to definitively mark the future treated area.
The BiomarC site marker is a zirconium oxide covered with a carbon coating.
This formulation allows the marker to be permanently visible under MRI as well as X-rays and ultrasound.
- Carbon markers of breast sites treated with adjuvant chemotherapy
- Permanent breast site marker visible on X-rays, ultrasound, CT scan and MRI.
- The marker is released using a manual pusher at the end of a flexible guide.
Technical data:
- Zirconium oxide marker with carbon coating
- 11G manual launcher
- Needle length 16.5 cm
- 2x4 mm marker
- Permanent visibility
- Sterile
- CE Class IIb medical device
- Packaged in a box of 10 sterile markers
The BiomarC site marker is a zirconium oxide covered with a carbon coating.
This formulation allows the marker to be permanently visible under MRI as well as X-rays and ultrasound.
- Carbon markers of breast sites treated with adjuvant chemotherapy
- Permanent breast site marker visible on X-rays, ultrasound, CT scan and MRI.
- The marker is released using a manual pusher at the end of a flexible guide.
Technical data:
- Zirconium oxide marker with carbon coating
- 11G manual launcher
- Needle length 16.5 cm
- 2x4 mm marker
- Permanent visibility
- Sterile
- CE Class IIb medical device
- Packaged in a box of 10 sterile markers
- UGAP reference
- 4047242
- Net weight kg
- 0,20
- Packing
- 44x13x10cm
- Gross weight kg
- 0,20
- CE
- DM Classe IIb